stock-mb-logo-androidstock-mb-logo-ios
Stock Screener App
Free - Play StoreApp Store
InstallInstall
logo
Mirum Pharmaceuticals IncMIRM
$89.841.90%-1.74

Mirum Pharmaceuticals Inc (MIRM)

Mirum Pharmaceuticals Inc stock is traded at $89.84, with a volume of 48,561. It is down -1.90% in the last 24 hours and up +12.10% over the past month. Mirum Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing therapies for rare and orphan diseases. Its main product, Livmarli (maralixibat), is an orally administered IBAT inhibitor approved to treat cholestatic pruritus in patients with Alagille syndrome. The company is also developing treatments such as maralixibat for PFIC and ALGS, and volixibat for adult cholestatic liver diseases. Mirum currently has three approved medicines: Livmarli, Cholbam, and Ctexli.
Previous Close:
$91.58
Open:
$91.00
24h Volume:
48,561
Relative Volume:
0.07
Market Cap:
$5.86B
Revenue:
$569.61M
Net Income/Loss:
-$23.36M
P/E Ratio:
-
EPS:
-$13.60
Net Cash Flow:
$54.87M
1W Performance:
-4.85%
1M Performance:
+12.10%
6M Performance:
-12.08%
1Y Performance:
+24.41%
1-Day Range:
$89.56$92.31
1-Week Range:
$89.56$95.37
52-Week Range:
$63.23$130.00

Mirum Pharmaceuticals Inc Stock (MIRM) Company Profile

Name
Mirum Pharmaceuticals Inc
Phone
650-667-4085
Address
989 EAST HILLSDALE BOULEVARD, SUITE 300, FOSTER CITY, USA
Employee
372
Next Earnings Date
-
Latest SEC Filings
SEC
MIRM's Discussions on X
X

 

Market Cap

 

Revenue

 

Net Income

 

Cash Flow

 

EPS

 

Mirum Pharmaceuticals Inc Stock (MIRM) Financials Data

Similar to MIRM